< Back to previous page
Researcher
Rik Lories
- Disciplines:Orthopaedics not elsewhere classified, Regenerative medicine not elsewhere classified
Affiliations
- Skeletal Biology and Engineering Research Center (Division)
Responsible
From1 Oct 2020 → Today - Department of Development and Regeneration (Department)
Responsible
From1 Aug 2020 → Today - Skeletal Biology and Engineering Research Center (Division)
Member
From1 Apr 2013 → Today - Allergy and Clinical Immunology Research Group (Division)
Member
From1 Oct 1999 → 30 Sep 2002
Projects
1 - 10 of 61
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Insights into the susceptibility to viral infections in ADA2 deficiencyFrom26 Apr 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Lipids: hitherto unknown mediators of cartilage homeostasis and disease with a role in osteoarthritisFrom1 Jan 2022 → TodayFunding: FWO research project
- Effective mechanotherapy in early osteoarthritis through modulation of Wnt-induced integrin/cytoskeleton axis dysregulation.From8 Nov 2021 → TodayFunding: FWO fellowships
- Single cell technologies applied to healthy articular cartilage profiling.From1 Nov 2021 → TodayFunding: Other federal public and semi-governmental institutions
- Maintaining and restoring joint homeostasis in chronic arthritisFrom1 Oct 2021 → TodayFunding: FWO fundamental clinical research fellowship
- Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European StatesFrom1 Jul 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- Development of hydrogels to support chondrocyte responsiveness to mechanical loadingFrom18 Nov 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Rehab-4-earlyOA: Mechanobiology-driven rehabilitation of early osteoarthritis through optimized multi-scale biomechanicsFrom1 Nov 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 229
- Hypoxia and Wnt signaling inversely regulate expression of chondroprotective molecule ANP32A in articular cartilage.(2023)
Authors: Jolien Quintiens, Astrid De Roover, Frederique Cornelis, An Sermon, Silvia Monteagudo, Rik Lories
Pages: 507 - 518 - Inhibiting thyroid activation in aged human explants prevents mechanical induced detrimental signalling by mitigating metabolic processes(2022)
Authors: Frederique Cornelis, Rik Lories
Pages: 457 - 466 - Omics and Multi-Omics Analysis for the Early Identification and Improved Outcome of Patients with Psoriatic Arthritis(2022)
Authors: Rik Lories
- THE PATTERN OF JOINT INFLAMMATION IN THE CAIA MOUSE MODEL OF ARTHRITIS(2022)
Authors: Koenraad Van Laere, Rik Lories, Barbara Neerinckx
Pages: 1184 - 1184 - Mechanosensors control skeletal muscle mass, molecular clocks, and metabolism(2022)
Authors: Mathias Vanmunster, Sebastiaan Dalle, Katrien Koppo, Ilse Jonkers, Rik Lories, Frank Suhr
- Levelling the playing field of RMD research across Europe to address patients' needs: the emerging EULAR Research Centre(2022)
Authors: Rik Lories
- ANP32A represses Wnt signaling across tissues thereby protecting against osteoarthritis and heart disease(2022)
Authors: Silvia Monteagudo, Frederique Cornelis, Astrid De Roover, Jolien Quintiens, An Sermon, Rik Lories
Pages: 724 - 734 - THE TIME-COURSE OF CHANGES IN INFLAMMATION AND ITS RESOLUTION IN THE DESTABILIZATION OF MEDIAL MENISCUS MOUSE MODEL OF OSTEOARTHRITIS(2022)
Authors: Frederique Cornelis, Silvia Monteagudo, Rik Lories
Pages: S226 - S226 - Systematic review of the use of CRP in clinical trials for psoriatic arthritis: a concern for clinical practice?(2022)
Authors: Kurt De Vlam, Barbara Neerinckx, Rik Lories
- Real-World Efficacy and Safety of Apremilast in Belgian Patients with Psoriatic Arthritis: Results from the Prospective Observational APOLO Study(2022)
Authors: Kurt De Vlam, Rik Lories
Pages: 1055 - 1067
Patents
1 - 1 of 1
- INHIBITOR OF CALCIFYING DISORDERS (Inventor)